FASN and hepatocellular carcinoma: Through different oncogene-induced HCC mouse models, such as AKT, AKT/c-Met and c-Met/β-catenin models, it has been observed that genetic ablation of FASN totally abolished hepatocarcinogenesis driven by AKT and AKT/c-Met [150,152,153].